Navigation Links
GE Medical Systems Signs Clinical Trial with National Cancer Institute

By using agents like FLT that can specifically image proliferation and other aspects of tumor biology, we can look at tumors before and soon after treatment to determine reliably whether a given therapy will be effective or not," Thrall said. "The idea is to personalize therapy by using PET imaging of the cancer to choose the right treatment and enable the patient to avoid inappropriate therapy." ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 11/24/03


Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Medical College team creates website for tracking flu
3. Medical College receives $1.4M cancer grant
4. Medical technology firm lands $100K federal grant
5. Doyle outlines spending for Medical College, UWM
6. Medical College lands $8.1M grant to detect bird flu, bioterror agents
7. Medical College dedicates $140M research facility
8. Dunn to step down as Medical College dean
9. Medical College team seeks stem cell patent
10. Medical College part of $5M cancer study
11. Medical College secures $9.7M research grant
Post Your Comments:
(Date:5/27/2015)...  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ("NW ... for cancer, announced today that Dr. Marnix L. ... be making an Industry Expert Theater Presentation at the ... on Saturday, May 30, 2015, from 3 to ... McCormick Place. Dr. Bosch will provide an ...
(Date:5/27/2015)... 27, 2015  Ceres, Inc. (Nasdaq: CERE ), ... patent for a genetic sequence derived from soybean, covering ... product development and plant transformation. The company believes that ... that are the target of a class of commercial ... commercial license to the innovation, including an opportunity for ...
(Date:5/27/2015)... MARLBOROUGH, Mass. , May 27, 2015 /PRNewswire/ ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today provided an update on the status of ... Stock. Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... there were 3,085 and 21 shares of Series ...
(Date:5/27/2015)... ­ Caris Life Sciences®, a leading biotechnology ... today announced it has appointed the Levine Cancer Institute, ... site in the Caris Centers of Excellence for Precision ... is one of the largest cancer care providers throughout ... patients annually. Derek Raghavan , M.D., Ph.D., President ...
Breaking Biology Technology:NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4
... HARBIN, China , May ... ("China Sky One Medical" or "the Company") (Nasdaq: ... producing over-the-counter drugs in, the People,s Republic of ... Long,Pharmaceutical Company ("Tian Long") subsidiary successfully obtained renewal,of ...
... NEW YORK , May 27 Pfizer Inc. (NYSE: ... to the EMPHASIS-HF trial early on the recommendations of the trial,s ... analysis by the independent Data Safety Monitoring Committee (DSMC) of the ... early according to the protocol pre-defined stopping rules. , ...
... in the College of Engineering at Virginia Tech, has ... to support development of a carbon nanotube-enhanced composite for ... huge wind turbine blades. Powe awards provide seed ... member institutions. These awards are intended to enrich the ...
Cached Biology Technology:China Sky One Medical Receives GMP Re-Certification 2China Sky One Medical Receives GMP Re-Certification 3Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 2Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 3Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 4Pfizer Announces EMPHASIS-HF Trial to Halt Recruitment due to Significant Benefit Observed in Patients Treated With Inspra® (Eplerenone) 5Powe Award supports development of nanocomposites to monitor wind turbine blade structure 2
(Date:5/19/2015)... -- Technology is rapidly advancing, outpacing enterprises, ability to secure ... and their management are soon to be rendered obsolete ... as those developed by the FIDO Alliance™. With the ... BYOD, COPE, IoT, and mobile payments, the interconnected online ... In response to the call for seamless, secure, ...
(Date:5/11/2015)... SAN JOSE, Calif. , May 11, 2015 ... leading developer of human interface solutions, today announced ... Senior Vice President and Chief Financial Officer, reporting ... Mr. Ali replaces Synaptics, current Chief Financial Officer, ... in December 2014. Mr. Ali ...
(Date:5/7/2015)... , May 7, 2015 ... fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest touch ... FPC1035 are mainly considered for integration on the ... gives smartphone OEMs increased possibilities to integrate touch ... decreased size also improves possibilities for module manufacturers ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... Biological and Environmental Nanotechnology (CBEN) have developed a ... human cell that is programmed to light up ... of particular proteases is a common hallmark of ... the September issue of the journal Biochemical and ...
... The most detailed analysis to date of how humans differ ... that natural selection has shaped the recent evolution of our ... Celera Diagnostics. , In a study published in the ... 11,624 genes, comparing how genes vary not only among 39 ...
... a 'living gel' that could be applied to the ... , The researchers genetically modified bacteria that are normally ... protein that stops the HIV virus from infecting cells. ... the internal body surfaces where HIV transmission can occur ...
Cached Biology News:'Smart' nanoprobes light up disease 2Cornell finds natural selection in humans 2Cornell finds natural selection in humans 3Living anti-HIV gel shows early promise 2